Zintinus

2022年9月12日

Lykon,创业超越食物和healthtech垂直,刚刚获得€1000万。柏林业务的使命是让人们通过认证的权力掌控自己的健康营养建议。数字医疗是今天的大趋势之一,它是帮助欧洲人控制自己的健康,从舒适的家中访问医疗建议。来是由于苦苦挣扎的卫生保健系统和大流行性流感暴露内部创新和数字化医疗的必要性。我们的健康的一个方面,正面临着越来越严格的审查在现代世界,是我们的饮食和营养。随着现代饮食变得更多的加工,和食品技术创新者寻找可持续和健康的替代传统食品,关注我们的营养变得越来越盛行了。他们说你是你吃什么,事实是,没有两具尸体都是相同的。我们都需要不同的饮食来保持健康,营养知识是实现这一根本。反映这个问题,数字医疗方法,通过分析营养和提供个性化的建议,德国启动Lykon刚刚筹集了1000万€。成立于2018年,Lykon发展个性化营养概念和膳食补充剂基于实验室诊断血液和DNA分析,人工智能和医学研究。 With just a few drops of blood or saliva, which can be collected at home, the startup is able to provide customers with tailored nutrition and action recommendations to help them achieve their health goals. Customers order the Lykon tests at home, perform them at home and send the samples by post. The samples are analyzed in a lab and the results are presented on an individual Lykon profile with clear certified nutritional recommendations. Tobias Teuber: “The way we eat should be as unique as every one of us.” Funding details The €10 million Series A round was led by venture capital investor Zintinus. The round also includes participation from venture debt provider BTG – Bridge To Growth, as well as existing investors including MA Ventures, the venture capital fund of Swiss retailer Migros Aare (managed by Redstone) and media group Ippen Digital. With the closing of the financing round, a new brand identity was unveiled at the sametime. The aim is that this will help boost awareness of the benefits of personalized, science-based nutrition. Lykon founder and CEO Tobias Teuber commented: “We are proud to have attracted Zintinus and other investors like BTG. Together with the investors and our Lykonians, we are advancing our mission to build the leading ecosystem for personalized nutrition worldwide. We will use the capital raised to further increase the user-friendliness of our products and to develop new markets and target groups.” - Advertisement -